The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
gsk vaccine sales decline amid lower demand for rsv and shingles shots
GSK's vaccine sales plummeted in the third quarter, with shingles vaccine sales down 7% and respiratory syncytial virus (RSV) shot Arexvy dropping 72% year over year. The decline is attributed to a narrower CDC recommendation, prioritization of COVID vaccinations, and lower RSV infection rates. GSK anticipates a low single-digit decline in overall vaccine sales for the year.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.